Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularizations Associated with Pathologic Myopia: A Prospective Study

Publisher： Karger

E-ISSN： 1423-0267|233|1|2-7

ISSN： 0030-3755

Source： Ophthalmologica, Vol.233, Iss.1, 2014-12, pp. : 2-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Ranibizumab in the Treatment of Butterfly-Shaped Pattern Dystrophy Associated with Choroidal Neovascularization: A Case Report

By  

Case Reports in Ophthalmology, Vol. 3, Iss. 1, 2012-02 ,pp. : 77-82

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab for Choroidal Neovascularization Secondary to Pathological Myopia: 12-Month Follow-Up

By  

Ophthalmologica, Vol. 226, Iss. 3, 2011-06 ,pp. : 103-109

Karger

Access to resources Recommend Favorite

Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma

By  

Case Reports in Ophthalmology, Vol. 3, Iss. 2, 2012-06 ,pp. : 200-204

Karger

Access to resources Recommend Favorite

Ranibizumab Treatment for Choroidal Neovascularization from Causes Other than Age-Related Macular Degeneration and Pathological Myopia

By  

Ophthalmologica, Vol. 225, Iss. 2, 2010-09 ,pp. : 81-88

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab Injection for Idiopathic Choroidal Neovascularization in Children

By Kim Rebecca   Kim Yu Cheol  

Seminars in Ophthalmology, Vol. 29, Iss. 3, 2014-05 ,pp. : 178-181

Informa Healthcare

Access to resources Recommend Favorite